Back

Determinants of left ventricular ATP availability measured in vivo and ex vivo in patients with severe aortic stenosis: correlation of creatine kinase activity with LVEF and ATP diffusion distance

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Aortic valve replacement: diagnostic and treatment considerations Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mark Andrew Peterzan

St George's Hospital (London), London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Clinical characteristics and outcomes after TAVI in patients reclassified to moderate aortic stenosis by integration of multimodality imaging and pressure recovery
Doctor E. Holy (Zurich, CH)
Abstract Slides
Presentation thumbnail
Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.
Doctor A. Guha (Augusta, US)
Abstract Slides
Presentation thumbnail
Predictors of short- and mid-term outcomes after TAVR in low-flow, low-gradient aortic stenosis
Doctor V. Emer Egypto Rosa (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Single-center experience with different regimes of antiplatelet therapy and oral anticoagulation in transcatheter aortic valve replacement
Doctor V. Veulemans (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Left-sided deviation and fibrous-fatty infiltration of the right bundle branch in the elderly: implication for transcatheter aortic valve implantation (TAVI) procedure
Professor J. Cabrera (Pozuelo de Alarcon, Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Aortic valve replacement: diagnostic and treatment considerations

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources